Winning the Fight Against COVID-19: Why Our New Biotech Stock Has Huge Potential


People will pay whatever they can afford for life, health, and shelter. They are necessity goods.

It takes years to become a medical specialist. As in many developed countries, public healthcare must be rationed. Surgeons are in demand in the private sector. And an ageing population presents increased demand.

The New Zealand housing market shows signs of serious market failure. The building industry is strangled by regulation and land-use restrictions. So it could not keep pace with government mass-migration oversight.

Now the future outlook for very high prices is less than certain. Though other locations could show opportunity.

We have a few property-tied businesses in our portfolio. Awaiting market recovery in Europe. So, today, I am more interested in the medical area.

In particular, any business that can assist in the health recovery from COVID-19. And other serious ailments.

We just found one. A speculative biotechnology company. Its approach makes a lot of sense. Let me explain…


Premium Article Profitable

Already a Member? Sign In Here

Daily Wealth

Daily Wealth

Subscribe now to get your exclusive eBook report — ‘Growth & Income: Why You Can’t Ignore This Property Stock Now’ — and receive the investor’s newsletter and podcast capturing the most decisive financial events that could impact your wealth.

By clicking Subscribe, you agree you’ve read and accepted our Privacy Policy. You can cancel at any time.

Simon is the Chief Executive Officer and Publisher at Wealth Morning. He has been investing in the markets since he was 17. He recently spent a couple of years working in the hedge-fund industry in Europe. Before this, he owned an award-winning professional-services business and online-learning company in Auckland for 20 years. He has completed the Certificate in Discretionary Investment Management from the Personal Finance Society (UK), has written a bestselling book, and manages global share portfolios. Simon is a shareholder of Wealth Morning.

HTML Snippets Powered By :
Wealth Morning Stock Market News, Finance and Investments